The House Republican Freedom Caucus for some reason certainly doesn't seem to be too concerned about prescription drug prices or the older Republican voters suffering because they're so high, going so far as to publicly warn pharmaceutical companies not to cooperate with the House Oversight Committee's investigation to determine why Americans pay more for prescription drugs than any other country on Earth.
In an unusual move, House Republicans are warning drug companies against complying with a House investigation into drug prices.
Republicans on the House Oversight Committee sent letters to a dozen CEOs of major drug companies warning that information they provide to the committee could be leaked to the public by Democratic chair Elijah Cummings in an effort to tank their stock prices.
Cummings requested information from 12 drug companies such as Pfizer Inc., Johnson & Johnson, and Novartis AG in January as part of a broad investigationinto how the industry sets prescription drug prices.
In their letters, Reps. Jim Jordan and Mark Meadows — leaders of the hardline conservative House Freedom Caucus — imply that Cummings may be attempting to collect the information in order to bring down the industry’s stock prices.
They write that Cummings is seeking sensitive information “that would likely harm the competitiveness of your company if disclosed publicly.” They then accuse Cummings of “releasing cherry-picked excerpts from a highly sensitive closed-door interview” conducted in an investigation into White House security clearances. “This is not the first time he has released sensitive information unilaterally,” says the letter. The authors say they “feel obliged to alert” the drug companies of Cummings’ actions.
Democrats expressed bafflement at the letters. While politicians routinely spar over committee work, warning companies not to comply with an investigation is unconventional — perhaps even unprecedented, Democrats say.
“Rep. Jordan is on the absolute wrong side here,” Cummings said in an emailed statement to BuzzFeed News. “He would rather protect drug company ‘stock prices’ than the interests of the American people.”
In their letter, Jordan and Meadows say that “while we cannot speculate about Chairman Cummings’ motives,” the committee should not pursue an investigation designed to impact stock prices.
It's ridiculous on its face, and I can't see how siding with the folks making insulin cost thousands of dollars per dose over Americans is going to help the GOP in 2020, but hey, keep making this about health care, guys.